Alpha Tau Medical develops and commercializes Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy), a targeted treatment for solid tumors that utilizes interstitial alpha-emitting sources to deliver localized radiation while minimizing damage to surrounding healthy tissue. This technology addresses the challenge of effectively treating various cancers, including skin, prostate, and pancreatic cancers, by providing a highly potent and conformal radiation dose directly within the tumor.

The startup develops a personalized health platform for pharmacy chains that includes customized point-of-sale systems, interior and exterior design support, and pharmacist training. This approach enables pharmacies to enhance patient trust and deliver tailored healthcare services while managing their operations independently.

Connecteve develops AI-based software and robotics solutions for the healthcare sector. Their core offerings include the CONNEVO KOA AI analysis software and the Vision AI-based artificial joint surgery robot. The company leverages extensive, verified data to create evidence-based medical technology for improved patient care.

E INC enhances the automotive purchasing process by providing a digital platform that streamlines wholesale and retail transactions through advanced technology and data analytics. This approach addresses inefficiencies in the automotive ecosystem, enabling faster and more flexible business operations for dealers and consumers.

The startup develops a healthcare platform that includes a wearable exercise device and a digital therapeutic system for knee joint rehabilitation, utilizing statistical inference, motion recognition, and machine learning. This technology provides healthcare professionals with personalized therapy regimens based on academic evidence, enhancing the safety and effectiveness of rehabilitation exercises for patients.

Inocras Inc. utilizes whole genome sequencing and a proprietary bioinformatics platform to provide detailed genetic insights for patients with cancer and rare diseases. This technology identifies complex mutations often missed by standard tests, enabling more accurate diagnoses and personalized treatment options.

Omi is a 3D AI application that generates high-quality product visuals for e-commerce and social media, enabling brands to create engaging content quickly and efficiently. By reducing photoshoot costs by 90% and increasing conversion rates by 19%, Omi addresses the need for consistent and compelling visual marketing across various platforms.

PROMEDIUS develops AI software to support healthy aging by analyzing medical imaging data. Their Osteo Signal product provides osteoporosis diagnosis support using chest X-rays, while Myo Signal offers muscle and fat segmentation from abdominal CT scans. This technology aims to improve diagnostic workflows and early detection for age-related conditions.

The startup has developed a handheld microscope that enables real-time in-vivo imaging of tumor tissues during cancer surgery. This technology allows surgical teams to visualize cancer cells clearly, improving the accuracy of tumor resections and enhancing patient outcomes.